NIH NIA Seamless Early-Stage Clinical Drug Development (Phase 1 to 2a) for Novel therapeutic Agents for the Spectrum of Alzheimer's Disease (AD) and AD-related Dementias (ADRD) (UG3/UH3 Clinical Trial Required)
NIH NIMH Early Stage Testing of Pharmacologic or Neuromodulatory Device-based Interventions for the Treatment of Mental Disorders (R61/R33 Clinical Trial Required)
NIH NIMH Early Stage Testing of Pharmacologic or Neuromodulatory Device-based Interventions for the Treatment of Mental Disorders (R33- Clinical Trial Required)
NIH NIDA NEI NIA NIAAA NIMH NINDS BRAIN Initiative: Brain-Behavior Quantification and Synchronization - Transformative and Integrative Models of Behavior at the Organismal Level (U01 Clinical Trials Not Allowed)
NIH NIDA NEI NIA NIAAA NIMH NINDS BRAIN Initiative: Brain-Behavior Quantification and Synchronization - Transformative and Integrative Models of Behavior at the Organismal Level (U01 Clinical Trial Optional)
NIH NEI NIA NIAAA NIDCD NIDA NINDS BRAIN Initiative: Research on the Ethical Implications of Advancements in Neurotechnology and Brain Science (R01 Clinical Trial Optional)
NIH NEI NIA NIAAA NIDCD NIDA NINDS BRAIN Initiative: Research on the Ethical Implications of Advancements in Neurotechnology and Brain Science (R21 Clinical Trial Optional)
NIH NIMH Utilizing Invasive Recording and Stimulating Opportunities in Humans to Advance Neural Circuitry Understanding of Mental Health Disorders (R01 Clinical Trial Optional)
